β-cyclodextrin-poly(β-amino ester) nanoparticles for sustained drug delivery across the blood-brain barrier

Biomacromolecules

Volumn 13, Issue 11, 2012, Pages 3533-3541

  Gil, Eun Seok ^a,c   Wu, Linfeng ^a,b   Xu, Lichong ^a   Lowe, Tao Lu ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Tufts University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ESTERS; ATOMIC FORCE; ATTENUATED TOTAL REFLECTANCE FOURIER TRANSFORM INFRARED SPECTROSCOPY; BIODEGRADABLE POLYMERIC NANOPARTICLES; BLOOD-BRAIN BARRIER; CHRONIC DISEASE; DOXORUBICIN; DRUG CARRIER; HUMAN BRAIN-MICROVASCULAR ENDOTHELIAL CELLS; IN-VITRO; LOADING EFFICIENCY; MATRIX-ASSISTED LASER; MICHAEL ADDITIONS; TIME OF FLIGHT;

ADDITION REACTIONS; ATOMIC FORCE MICROSCOPY; BLOOD; DRUG DELIVERY; ENDOTHELIAL CELLS; ESTERIFICATION; ESTERS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MONOLAYERS; NANOPARTICLES;

SYNTHESIS (CHEMICAL);

BETA CYCLODEXTRIN; DOXORUBICIN; NANOCARRIER; POLY(BETA AMINO ESTER); POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ATOMIC FORCE MICROSCOPY; BLOOD BRAIN BARRIER; CHEMICAL STRUCTURE; CROSS LINKING; DEGRADATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICHAEL ADDITION; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SYNTHESIS; TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CATTLE; CELLS, CULTURED; DOXORUBICIN; DRUG CARRIERS; ENDOTHELIAL CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ATOMIC FORCE; MICROVESSELS; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; POLYMERS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

BOVINAE;

EID: 84869074363     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm3008633     Document Type: Article

References (53)

1. Blakeley, J. Curr. Neurol. Neurosci. Rep. 2008, 8, 235-241
2. Pardridge, W. M. Drug Discovery Today 2007, 12, 54-61
3. Abbott, N. J.; Ronnback, L.; Hansson, E. Nat. Rev. Neurosci. 2006, 7, 41-53
4. Edwards, R. H. Nat. Neurosci. 2001, 4, 221-222
5. Herve, F.; Ghinea, N.; Scherrmann, J. M. AAPS J. 2008, 10, 455-472
6. Jones, A. R.; Shusta, E. V. Pharm. Res. 2007, 24, 1759-1771
7. Hu, K. L.; Li, J. W.; Shen, Y. H.; Lu, W.; Gao, X. L.; Zhang, Q. Z.; Jiang, X. G. J. Controlled Release 2009, 134, 55-61
8. Kreuter, J.; Ramge, P.; Petrov, V.; Hamm, S.; Gelperina, S. E.; Engelhardt, B.; Alyautdin, R.; von Briesen, H.; Begley, D. J. Pharm. Res. 2003, 20, 409-416
9. Kulkarni, P. V.; Roney, C. A.; Antich, P. P.; Bonte, F. J.; Raghu, A. V.; Aminabhavi, T. M. Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2010, 2, 35-47
10. Lu, W.; Tan, Y. Z.; Hu, K. L.; Jiang, X. G. Int. J. Pharm. 2005, 295, 247-260
11. Ulbrich, K.; Hekmatara, T.; Herbert, E.; Kreuter, J. Eur. J. Pharm. Biopharm. 2009, 71, 251-256
12. Alyautdin, R. N.; Petrov, V. E.; Langer, K.; Berthold, A.; Kharkevich, D. A.; Kreuter, J. Pharm. Res. 1997, 14, 325-328
13. Fenart, L.; Casanova, A.; Dehouck, B.; Duhem, C.; Slupek, S.; Cecchelli, R.; Betbeder, D. J. Pharmacol. Exp. Ther. 1999, 291, 1017-1022
14. Gulyaev, A. E.; Gelperina, S. E.; Skidan, I. N.; Antropov, A. S.; Kivman, G. Y.; Kreuter, J. Pharm. Res. 1999, 16, 1564-1569
15. Xu, F.; Lu, W.; Wu, H. B.; Fan, L.; Gao, X. L.; Jiang, X. G. J. Drug Targeting 2009, 17, 423-434
16. Gelperina, S.; Maksimenko, O.; Khalansky, A.; Vanchugova, L.; Shipulo, E.; Abbasova, K.; Berdiev, R.; Wohlfart, S.; Chepurnova, N.; Kreuter, J. Eur. J. Pharm. Biopharm. 2010, 74, 157-163
17. Tahara, K.; Miyazaki, Y.; Kawashima, Y.; Kreuter, J.; Yamamoto, H. Eur. J. Pharm. Biopharm. 2011, 77, 84-88
18. Han, L.; Zhang, A.; Wang, H.; Pu, P.; Jiang, X.; Kang, C.; Chang, J. Hum. Gene Ther. 2010, 21, 417-426
19. Huang, R.; Ke, W.; Liu, Y.; Jiang, C.; Pei, Y. Biomaterials 2008, 29, 238-246
20. Ke, W.; Shao, K.; Huang, R.; Han, L.; Liu, Y.; Li, J.; Kuang, Y.; Ye, L.; Lou, J.; Jiang, C. Biomaterials 2009, 30, 6976-6985
21. Oliveira, J. M.; Salgado, A. J.; Sousa, N.; Mano, J. F.; Reis, R. L. Prog. Polym. Sci. 2010, 35, 1163-1194
22. He, H.; Li, Y.; Jia, X. R.; Du, J.; Ying, X.; Lu, W. L.; Lou, J. N.; Wei, Y. Biomaterials 2011, 32, 478-487
23. Gajbhiye, V.; Jain, N. K. Biomaterials 2011, 32, 6213-6225
24. Li, J.; Gu, B.; Meng, Q.; Yan, Z.; Gao, H.; Chen, X.; Yang, X.; Lu, W. Nanotechnology 2011, 22, 435101
25. Hwang, D. W.; Son, S.; Jang, J.; Youn, H.; Lee, S.; Lee, D.; Lee, Y. S.; Jeong, J. M.; Kim, W. J.; Lee, D. S. Biomaterials 2011, 32, 4968-4975
26. Dadparvar, M.; Wagner, S.; Wien, S.; Kufleitner, J.; Worek, F.; von Briesen, H.; Kreuter, J. Toxicol. Lett. 2011, 206, 60-66
27. Zensi, A.; Begley, D.; Pontikis, C.; Legros, C.; Mihoreanu, L.; Wagner, S.; Buchel, C.; von Briesen, H.; Kreuter, J. J. Controlled Release 2009, 137, 78-86
28. Ziemba, B.; Janaszewska, A.; Ciepluch, K.; Krotewicz, M.; Fogel, W. A.; Appelhans, D.; Voit, B.; Bryszewska, M.; Klajnert, B. J. Biomed. Mater. Res., Part A 2011, 99 A, 261-268
29. Duncan, R.; Izzo, L. Adv. Drug Delivery Rev. 2005, 57, 2215-2237
30. Fischer, D.; Li, Y.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T. Biomaterials 2003, 24, 1121-1131
31. Loftsson, T.; Stefansson, E. Acta Ophthalmol. Scand. 2002, 80, 144-150
32. Davis, M. E.; Brewster, M. E. Nat. Rev. Drug Discovery 2004, 3, 1023-1035
33. Cheng, J.; Khin, K. T.; Davis, M. E. Mol. Pharmaceutics 2004, 1, 183-193
34. Cheng, J.; Khin, K. T.; Jensen, G. S.; Liu, A.; Davis, M. E. Bioconjugate Chem. 2003, 14, 1007-1017
35. Davis, M. E. Adv. Drug Delivery Rev. 2009, 61, 1189-1192
36. Kim, C.; Shah, B. P.; Subramaniam, P.; Lee, K. B. Mol. Pharmaceutics 2011, 8, 1955-1961
37. Gil, E. S.; Li, J.; Xiao, H.; Lowe, T. L. Biomacromolecules 2009, 10, 505-516
38. Yuan, W.; Li, G.; Fu, B. M. Ann. Biomed. Eng. 2010, 38, 1463-1472
39. Yuan, W.; Li, G.; Gil, E. S.; Lowe, T. L.; Fu, B. M. Ann. Biomed. Eng. 2010, 38, 3268
40. Lynn, D. M.; Langer, R. J. Am. Chem. Soc. 2000, 122, 10761-10768
41. Lim, Y. B.; Kim, S. M.; Lee, Y.; Lee, W. K.; Yang, T. G.; Lee, M. J.; Suh, H.; Park, J. S. J. Am. Chem. Soc. 2001, 123, 2460-2461
42. Akinc, A.; Anderson, D. G.; Lynn, D. M.; Langer, R. Bioconjugate Chem. 2003, 14, 979-988
43. Chen, J.; Xing, M. M. Q.; Zhong, W. Polymer 2011, 52, 933-941
44. Ko, J.; Park, K.; Kim, Y. S.; Kim, M. S.; Han, J. K.; Kim, K.; Park, R. W.; Kim, I. S.; Song, H. K.; Lee, D. S.; Kwon, I. C. J. Controlled Release 2007, 123, 109-115
45. Jiang, M.; Wu, Y.; He, Y.; Nie, J. Polym. Int. 2009, 58, 31-39
46. Ming, J.; Tiewei, W.; Qing, X.; Yan, W. Mini-Rev. Med. Chem. 2009, 9, 1342-1356
47. Shen, Y.; Tang, H.; Zhan, Y.; Van Kirk, E. A.; Murdoch, W. J. Nanomedicine (Philadelphia, PA, U. S.) 2009, 5, 192-201
48. Rölling, P.; Lamers, M.; Staudt, C. J. Membr. Sci. 2010, 362, 154-163
49. Huang, X.; Lowe, T. L. Biomacromolecules 2005, 6, 2131-2139
50. Zheng, Y.; Zuo, Z.; L. Chow, A. H. Int. J. Pharm. 2006, 309, 123-128
51. Chang, Y. S.; Munn, L. L.; Hillsley, M. V.; Dull, R. O.; Yuan, J.; Lakshminarayanan, S.; Gardner, T. W.; Jain, R. K.; Tarbell, J. M. Microvasc. Res. 2000, 59, 265-277
52. Li, J.; Xiao, H.; Zhong, Y. Int. J. Pharm. 2004, 278, 329-342
53. Burns, E. M.; Dobben, G. D.; Kruckeberg, T. W.; Gaetano, P. K. Adv. Neurol. 1981, 30, 159-165